BioHarvest Sciences Inc. ... (BHST)
| Bid | 8.69 |
| Market Cap | 152.17M |
| Revenue (ttm) | 30.17M |
| Net Income (ttm) | -12.06M |
| EPS (ttm) | -0.69 |
| PE Ratio (ttm) | -12.72 |
| Forward PE | -214.25 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 9.29 |
| Volume | 130,204 |
| Avg. Volume (20D) | 29,946 |
| Open | 8.52 |
| Previous Close | 9.20 |
| Day's Range | 8.50 - 9.10 |
| 52-Week Range | 4.66 - 12.00 |
| Beta | 1.47 |
| Ex-Dividend Date | n/a |
About BHST
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for BHST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnalysts project revenue of ... Unlock content with Pro Subscription
1 week ago · proactiveinvestors.com
BioHarvest balance sheet gets $14.7m boos, including $11m of new investmentBioHarvest Sciences Inc. (NASDAQ:BHST) has strengthened its finances by pulling in $10.9 million in fresh investment and trimming $3.8 million in debt through a series of deals involving warrants and ...
3 weeks ago · seekingalpha.com
BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)BioHarvest Sciences Inc. (NASDAQ:BHST ) Virtual Investor Webinar Conference September 10, 2025 01:00 PM ET Company Participants Ilan Sobel - Chief Executive Officer Zaki Rakib - Co-Founder, Executive ...
3 weeks ago · proactiveinvestors.com
BioHarvest Sciences achieves large-scale production of plant-based exosomesBioHarvest Sciences Inc. (NASDAQ:BHST) announced it has successfully produced plant-based exosomes at scale in its proprietary bioreactors, a development the company says represents a breakthrough in ...
1 month ago · newsfilecorp.com
BioHarvest Sciences Reports Second Quarter 2025 Financial ResultsRobust 41% Year-Over-Year Revenue Growth, Driven by Strong Core Capsule and New Product Sales Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ...